CoChat

Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment

Open access

The DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.

Abstract

Increased understanding of pediatric acute lymphoblastic leukemia (ALL) pathobiology has led to dramatic improvements in patient survival. However, there is still a need to develop targeted therapies to enable reduced chemotherapy intensity and to treat relapsed patients. The interleukin-7 receptor α (IL-7Rα) signaling pathways are prime therapeutic targets because these pathways harbor genetic aberrations in both T-cell ALL and B-cell precursor ALL. Therapeutic targeting of the IL-7Rα signaling pathways may lead to improved outcomes in a subset of patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2016-03-679209

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 93 references

Research works printed but not linked: 1

  1. Gutierrez, 2015, Acute lymphoblastic leukemia., 1527

Cited by

See all 46

Metadata

Authors
Cramer, S. D., Aplan, P. D., & Durum, S. K.
Affiliations
National Institutes of Health (US)
Venue
Blood
Published
2016-07-28
Volume
128
Issue
4
Pages
473-478
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2418034645
Cited by
43
References
94
Citations by year
2026: 3 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 9 · 2017: 4 · 2016: 2
FWCI
1.05
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Multiple Sclerosis Society
  • Children's Cancer Foundation
  • Multiple Sclerosis Society
  • National Institutes of Health
  • National Cancer Institute (Z01BC010931, ZIABC009287, ZIASC010378)
Topics
  • Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
  • Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
Keywords
IL-7 receptor alpha, IL-7 signaling, childhood acute lymphoblastic leukemia, targeted therapy, T-cell acute lymphoblastic leukemia, B-cell precursor acute lymphoblastic leukemia, relapsed leukemia, reduced-intensity chemotherapy, genetic alterations
MeSH terms
Humans, Neoplasm Proteins, Signal Transduction, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Interleukin-7, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment. https://app.cochat.ai/papers/10.1182/blood-2016-03-679209
The paper
Cramer, S. D., Aplan, P. D., & Durum, S. K. (2016). Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment. Blood. https://doi.org/10.1182/blood-2016-03-679209

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.